Aileron Therapeutics Inc

NASDAQ:ALRN   3:59:54 PM EDT
1.05
+0.01 (+0.96%)
Earnings Announcements

Aileron Therapeutics Reports Third Quarter 2020 Financial Results

Published: 11/13/2020 02:25 GMT
Aileron Therapeutics Inc (ALRN) - Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights.
Net Loss Was $5.0 Million for Quarter Ended September 30, 2020, Compared to $7.7 Million for Corresponding Period in 2019.
Aileron Therapeutics - Cash, Cash Equivalents and Investments As of September 30, 2020 Were $14.1 Million, Compared to $18.3 Million As of December 31, 2019.
Aileron Therapeutics- Expect, Based on Current Operating Plan, That Cash, Cash Equivalents and Investments Will Fund Operations Into Q4 of 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.